Roche Holding AG (RHHVF) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - General industry. The company is headquartered in Basel, Switzerland. The current CEO is Thomas Schinecker.
RHHVF has IPO date of 2009-02-13, 103,249 full-time employees, listed on the Other OTC, a market capitalization of $321.02B.
Roche Holding AG is a Swiss pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, infectious diseases, immunology, and respiratory conditions, serving patients globally. Through its diagnostics division, Roche provides in vitro diagnostic tests, instruments, and reagents for detecting diseases such as cancer, cardiovascular conditions, diabetes, and infectious diseases including COVID-19. The company also pursues innovative research collaborations, including partnerships focused on synthetic biology treatments for conditions like inflammatory bowel disease. As an integrated healthcare company, Roche combines its pharmaceutical innovation with diagnostic capabilities to address major healthcare challenges worldwide.
